Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Insights - The company reported a revenue of 739 million yuan for 2025, representing a year-on-year growth of 19.91%, while the net profit attributable to shareholders was 66.72 million yuan, down 23.05% year-on-year due to rising raw material costs [2][3] - The gross margin for 2025 was 19.99%, a decline of 6.66 percentage points compared to 2024's 26.65% [2] - The company is expected to see net profits of 90 million yuan in 2026, 112 million yuan in 2027, and 136 million yuan in 2028, with corresponding EPS of 0.87, 1.09, and 1.32 yuan per share [2][5] Financial Performance Summary - Revenue for 2025 was 739 million yuan, with a year-on-year growth of 19.9% [5] - The net profit attributable to shareholders for 2025 was 66.72 million yuan, reflecting a year-on-year decline of 23.1% [5] - The gross margin for 2025 was 20.0%, down from 26.7% in 2024 [5] - The company’s R&D expenses increased by 16.32% in 2025, totaling 27.67 million yuan [4] - The company has 90 intellectual property rights, including 28 invention patents [4] Revenue and Profit Forecast - Projected revenues for 2026, 2027, and 2028 are 864 million yuan, 1.078 billion yuan, and 1.255 billion yuan, respectively [5] - Projected net profits for the same years are 90 million yuan, 112 million yuan, and 136 million yuan, with corresponding P/E ratios of 24.2, 19.3, and 15.9 [5][7]